Frontiers

Oncology Reviews Template

Write in a clean editor, then format for Oncology Reviews in one click — DocuGuru applies the official Frontiers template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.

About the Oncology Reviews format

Oncology Reviews is a peer-reviewed journal published by Frontiers, covering Cancer Treatment and Pharmacology, Cancer Genomics and Diagnostics, Head and Neck Cancer Studies. Over its lifetime it has published 820 papers, which have received 7,858 citations.

PublisherFrontiers
Reference styleNumbered (Vancouver)
Numbered — [1], [2] in the text
1. Smith A, Jones B, Lee C. A representative article title. Oncology Reviews. 2023;12(3):45–58.

Formats any DOI in Oncology Reviews style. No sign-up.

Publishes research inCancer Treatment and Pharmacology Cancer Genomics and Diagnostics Head and Neck Cancer Studies Breast Cancer Treatment Studies Renal cell carcinoma treatment
ISSN1970-5557
Citation impact (2-yr)4.24
h-index41
i10-index163
Article processing charge$1,900
Open accessYes — indexed in DOAJ
Top institutions publishing hereUniversity of Pavia
Journal websitewww.oncologyreviews.org
You getA submission-ready PDF and the editable LaTeX source — ready to submit.

Papers published in Oncology Reviews per year

16
2014
7
2015
13
2016
12
2017
19
2018
24
2019
20
2020
17
2021
9
2022
12
2023
34
2024
50
2025

Citation impact of Oncology Reviews by publication year

823
2014
266
2015
388
2016
1.2K
2017
605
2018
734
2019
632
2020
172
2021
301
2022
168
2023
256
2024
243
2025

Citations each year’s papers have accumulated so far — the most recent years are still building up.

Most-cited papers in Oncology Reviews

Bone metastases: an overview

Filipa Macedo, Kátia Ladeira, Filipa Pinho et al. · 9 May 2017

Bone is a frequent site of metastases and typically indicates a short-term prognosis in cancer patients. Once cancer has spread to the bones it can rarely be cured, but often it can still be treated to slow its growth. The majority of skeletal metastases are due to breast and prostate cancer. Bone metastasis is actually…

Epithelioid hemangioendothelioma: an overview and update on a rare vascular tumor

Angela Sardaro, Lilia Bardoscia, Maria Fonte Petruzzelli et al. · 13 Oct 2014

Epithelioid hemangioendothelioma is a rare vascular tumor, described for the first time in 1975 by Dail and Liebow as an aggressive bronchoalveolar cell carcinoma. The etiology is still a dilemma. Studies about suggestive hypothesis are ongoing. Most of the times it affects lung, liver and bones, although this kind of tumor may involve the head…

An overview on the role of FLT3-tyrosine kinase receptor in acute myeloid leukemia: biology and treatment

Tiziana Grafone, Michela Palmisano, Chiara Nicci et al. · 17 Apr 2012

Hematopoiesis, the process by which the hematopoietic stem cells and progenitors differentiate into blood cells of various lineages, involves complex interactions of transcription factors that modulate the expression of downstream genes and mediate proliferation and differentiation signals. Despite the many controls that regulate hematopoiesis, mutations in the regulatory genes capable of promoting leukemogenesis may occur.…

Red meat and colorectal cancer

Nuri Faruk Aykan · 28 Dec 2015

Colorectal cancer (CRC) is the third most common cancer in men and the second in women worldwide. More than half of cases occur in more developed countries. The consumption of red meat (beef, pork, lamb, veal, mutton) is high in developed countries and accumulated evidence until today demonstrated a convincing association between the intake of…

HER3 signaling and targeted therapy in cancer

Rosalin Mishra, Hima Patel, Samar Alanazi et al. · 16 May 2018

ERBB family members including epidermal growth factor receptor (EGFR) also known as HER1, ERBB2/HER2/Neu, ERBB3/HER3 and ERBB4/HER4 are aberrantly activated in multiple cancers and hence serve as drug targets and biomarkers in modern precision therapy. The therapeutic potential of HER3 has long been underappreciated, due to impaired kinase activity and relatively low expression in tumors.…

Oncology Reviews template — frequently asked questions

How do I write a paper in the Oncology Reviews format?
In DocuGuru you write your manuscript in a normal editor — no LaTeX setup required — and select the Oncology Reviews template. When you export, DocuGuru compiles the paper into the official Frontiers format and hands you a submission-ready PDF along with the editable LaTeX source.
What reference style does Oncology Reviews use?
Oncology Reviews uses Numbered (Vancouver) references, shown as numbered [1], [2] markers in the text. DocuGuru formats every in-text citation and the reference list in this exact style automatically. A reference appears like this: 1. Smith A, Jones B, Lee C. A representative article title. Oncology Reviews. 2023;12(3):45–58.
Do I need to know LaTeX to submit to Oncology Reviews?
No. DocuGuru generates the FrontiersinVancouver LaTeX class and compiles the PDF for you in the background, so you get a Frontiers-ready Oncology Reviews document without writing any LaTeX. If you do want it, the LaTeX source is included in the export.
Can I import an existing draft into the Oncology Reviews template?
Yes. Paste or upload your current manuscript — Word, LaTeX, Markdown, or plain text — and DocuGuru reflows it into the Oncology Reviews format with correct headings, figures, tables, and numbered citations.
What is Oncology Reviews?
Frontiers journal. It is a life sciences and medicine journal, published by Frontiers.
Can I export a submission-ready Oncology Reviews PDF?
Yes — DocuGuru produces a PDF built with the official Oncology Reviews template (the FrontiersinVancouver class) that is ready to submit to Frontiers, together with the matching LaTeX source files.
How much does the Oncology Reviews template cost?
You can start writing in the Oncology Reviews template for free. Exporting the final submission-ready Oncology Reviews PDF and LaTeX source is part of DocuGuru's paid plans — see the app for current pricing.
Use the Oncology Reviews template